...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: mCRPC and BET inhibitors

Judging from this very recent paper, there is some indpendent support for the hypothesis put forward by Zenith.

http://intl-mcr.aacrjournals.org/content/early/2016/01/20/1541-7786.MCR-15-0472.abstract

Br.

BKC

5
Jan 26, 2016 04:17PM
Share
New Message
Please login to post a reply